Literature DB >> 25606181

Can Primary Care Clinic Run MMT Service Well?

A Norsiah, S Dharmananda, Md Mohammad Nazri, Mm Marzafuan, Bwh Lee, My Khalijah.   

Abstract

Methadone Maintenance Therapy (MMT) for opiate dependence was first started in Malaysia in 2005. The service was initially provided by psychiatric clinics in hospitals and primary care clinics. Handling patients with opiate dependency especially in a primary care clinic is very challenging due to various constraints hence the success is doubtful. 143 patients from Tampin Health Clinic were recruited from November 2006 until March 2009. Retention rate in the program was high. Significant improvement was seen in the World Health Organization Quality Of Life score (WHOQOL-BREF) in all 4 domains done at baseline, 1st year and 2nd year in the program. After joining the program, there were no new blood borne virus infection for HIV and Hepatitis B and only 1 had Hepatitis C. Minimal number of patients were involved in new drug related offences while in the MMT program. Existing primary care clinics can be empowered to scale up this service in Malaysia.

Entities:  

Keywords:  Methadone Maintenance Therapy; opiate dependency; primary care clinic

Year:  2010        PMID: 25606181      PMCID: PMC4170387     

Source DB:  PubMed          Journal:  Malays Fam Physician        ISSN: 1985-2274


  10 in total

1.  World Health Organization Quality of Life Assessment: brief version in Bahasa Malaysia.

Authors:  C I Hasanah; L Naing; A R Rahman
Journal:  Med J Malaysia       Date:  2003-03

Review 2.  Methadone therapy for opioid dependence.

Authors:  L L Krambeer; W von McKnelly; W F Gabrielli; E C Penick
Journal:  Am Fam Physician       Date:  2001-06-15       Impact factor: 3.292

3.  Malaysia and harm reduction: the challenges and responses.

Authors:  Gary Reid; Adeeba Kamarulzaman; Sangeeta Kaur Sran
Journal:  Int J Drug Policy       Date:  2007-01-29

4.  The prepared mind: Marie Nyswander, methadone maintenance, and the metabolic theory of addiction.

Authors:  D T Courtwright
Journal:  Addiction       Date:  1997-03       Impact factor: 6.526

5.  Methadone maintenance in primary care: a randomized controlled trial.

Authors:  D A Fiellin; P G O'Connor; M Chawarski; J P Pakes; M V Pantalon; R S Schottenfeld
Journal:  JAMA       Date:  2001-10-10       Impact factor: 56.272

Review 6.  Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.

Authors:  M Connock; A Juarez-Garcia; S Jowett; E Frew; Z Liu; R J Taylor; A Fry-Smith; E Day; N Lintzeris; T Roberts; A Burls; R S Taylor
Journal:  Health Technol Assess       Date:  2007-03       Impact factor: 4.014

7.  High-risk behaviours and concomitant medical illnesses among patients at methadone maintenance therapy clinic, hospital tengku ampuan afzan, malaysia.

Authors:  M Ramli; Mz Nora; Aab Zafri; Mr Junid; Ak Umeed; Mi Hajee
Journal:  Malays Fam Physician       Date:  2009-08-31

8.  A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial.

Authors:  Amy E Gibson; Christopher M Doran; James R Bell; Anni Ryan; Nicholas Lintzeris
Journal:  Med J Aust       Date:  2003-07-07       Impact factor: 7.738

9.  The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis.

Authors:  L A Marsch
Journal:  Addiction       Date:  1998-04       Impact factor: 6.526

10.  Outpatient methadone maintenance treatment program. Quality of life and health of opioid-dependent persons in Lithuania.

Authors:  Zilvinas Padaiga; Emilis Subata; Giedrius Vanagas
Journal:  Medicina (Kaunas)       Date:  2007       Impact factor: 2.430

  10 in total
  1 in total

1.  Health-Seeking Behavior for Erectile Dysfunction in Methadone Maintenance Treatment Patients.

Authors:  Fitri Fareez Ramli; Ahmad Nazrun Shuid; Rashidi Mohamed Pakri Mohamed; Tg Mohd Ikhwan Tg Abu Bakar Sidik; Isa Naina Mohamed
Journal:  Int J Environ Res Public Health       Date:  2019-11-01       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.